UK Government to launch first ever men’s health strategy
Pharmaceutical Technology
NOVEMBER 29, 2024
The government said that men are less likely than women to seek medical help, particularly for mental health issues.
Fri.Nov 29, 2024
242 
Emotional body odors may enhance the effect of mindfulness therapy
Medical Xpress
NOVEMBER 29, 2024
Emotional body odors may have the potential to enhance the anxiety-reducing effects of mindfulness. This is shown by a pilot study published in the Journal of Affective Disorders, co-authored by researchers from Karolinska Institutet.
Join 21,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
EMA launches ESMP for better management of drug shortages in EU
Pharmaceutical Technology
NOVEMBER 29, 2024
The ESMP platform enables marketing authorisation holders to report shortages and will be mandatory from 2025.
The pink elephant test: What your visual imagination predicts about your ability to control your thoughts
Medical Xpress
NOVEMBER 29, 2024
"Tell a man he shouldn't think of a pink elephant and he can't get that beast out of his mind!
From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience
Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.
The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven
Formosa and Medvisis agree on post-operative eye pain therapy
Pharmaceutical Technology
NOVEMBER 29, 2024
Formosa has signed an exclusive licensing agreement with Medvisis for APP13007 for post-operative inflammation and pain after ocular surgery.
Gene-screening method identifies cause of heart cell damage from chemotherapy
Medical Xpress
NOVEMBER 29, 2024
Using a gene-screening method they created, Stanford Medicine researchers may have discovered why an effective chemotherapy damages heart cells—and they have identified a drug that could keep the heart cells beating.
Sign up to get articles personalized to your interests!
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
More Trending
Scientists identify key cells that could be targeted to prevent arthritis flare-ups
Medical Xpress
NOVEMBER 29, 2024
New research has pinpointed key cells that could be targeted to prevent painful rheumatoid arthritis flare-ups, offering potential new hope to millions of people with the condition world-wide.
Allink Biotherapeutics secures funding to advance ADC pipeline
Pharmaceutical Technology
NOVEMBER 29, 2024
Allink Biotherapeutics has completed a $42m Series A financing round to expedite the worldwide development of its ADC pipeline.
Low-curvature microelectrode arrays record spatial cognitive information coding in the deep brain
Medical Xpress
NOVEMBER 29, 2024
A research group led by Prof. Cai Xinxia from the Aerospace Information Research Institute (AIR) of the Chinese Academy of Sciences developed a new method for fabricating high-precision, low-curvature microelectrode arrays (MEAs), which are designed for recording neuronal activities in the brain's deep small volume region. The study was published in Microsystems & Nanoengineering.
University of Birmingham identifies target to reduce GVHD risk
Pharmaceutical Technology
NOVEMBER 29, 2024
University of Birmingham researchers have identified CD70 as a key target to reduce the risk of GVHD in blood cancer patients.
Study: Moderate alcohol, oily fish, cereal lower arthritis risk; tea, coffee may raise it
Medical Xpress
NOVEMBER 29, 2024
Moderate alcohol intake and eating more fruit, oily fish and cereals are linked to lower risk of rheumatoid arthritis, while tea and coffee may be linked to increased risk, new research shows.
UK reports near eradication of meningitis C amid declining vaccine uptake
Pharmaceutical Technology
NOVEMBER 29, 2024
Meningitis C cases are down 99% since the NHS routine vaccination programme was introduced by UKHSA and NHS England in 1999.
Black Friday: Why our brains love a bargain
Medical Xpress
NOVEMBER 29, 2024
Do you prefer Black Friday or Cyber Monday? The January sales or Amazon's Prime Day? Or perhaps you like to hold out for a good old-fashioned everything-must-go shop clearance.
Kelun's MSD-partnered TROP2 drug gets first okay in China
pharmaphorum
NOVEMBER 29, 2024
Kelun-Biotech has become the second drugmaker to bring a TROP2 ADC to regulatory approval, after its sac-TMT drug was cleared in China
The New Age of Decentralized Clinical Trials
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
First new treatment for asthma and COPD in half a century—new study
Medical Xpress
NOVEMBER 29, 2024
Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease (COPD) symptoms. For decades, the standard treatment for these potentially life-threatening episodes has remained unchanged—treatment with steroids, such as prednisolone.
Govorestat Hits Roadblock: FDA Denies Approval for Applied Therapeutics’ Rare Disease Drug
XTalks
NOVEMBER 29, 2024
The US Food and Drug Administration (FDA) has rejected the New Drug Application (NDA) for govorestat (AT-007), an investigational treatment for classic galactosemia, citing deficiencies in its clinical application. This decision, communicated through a Complete Response Letter, means the drug cannot currently proceed to market. Applied Therapeutics, the developer, plans to meet with the FDA to address the issues and explore options for resubmission.
Genetic study discovers mechanisms that make Ewing sarcoma more aggressive
Medical Xpress
NOVEMBER 29, 2024
Ewing sarcoma is a tumor of the bones and soft tissues that occurs in children and young people. Like all childhood cancers, it is rare—nine to 10 cases per million inhabitants per year—but it is very aggressive: 25% of patients do not respond well to regular therapy and they often experience relapses.
Sanofi opens $595m manufacturing facility in Singapore
pharmaphorum
NOVEMBER 29, 2024
Sanofi has officially opened a modular biologics manufacturing facility in Singapore that is designed to allow rapid switching between products.
Four struggles men face during the transition to fatherhood
Medical Xpress
NOVEMBER 29, 2024
Becoming a father can be a daunting life transition which, for many men, can be a stressful and isolating experience. Yet, fathers often lack access to support and information to help them cope during this transition. This is significant, as lack of support may increase a father's risk of developing mental health problems such as postnatal depression, which affects 1 in 10 UK fathers.
Poseida Joins Roche in $1.5B Deal to Deliver Next-Gen CAR-T Therapies
XTalks
NOVEMBER 29, 2024
Roche has entered into a definitive agreement to acquire Poseida Therapeutics, a San Diego-based biopharmaceutical company advancing cutting-edge off-the-shelf chimeric antigen receptor T-cell (CAR-T) therapies. The deal, valued at approximately $1 billion in upfront cash and up to an additional $500 million in milestone payments, is expected to close in the first quarter of 2025.
Adcendo raises $135m for cancer ADCs, and other financings
pharmaphorum
NOVEMBER 29, 2024
Adcendo raises $135m for cancer ADCs, plus financings for Enveda, Cradle Bio, ATB Therapeutics, and 35Pharma
Algorithms based on deep learning can improve medical image analysis
Medical Xpress
NOVEMBER 29, 2024
Artificial intelligence has the potential to improve the analysis of medical image data. For example, algorithms based on deep learning can determine the location and size of tumors. This is the result of AutoPET, an international competition in medical image analysis, where researchers of Karlsruhe Institute of Technology (KIT) were ranked fifth.
The New Age of Decentralized Clinical Trials
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
UK government commits to first men's health strategy
pharmaphorum
NOVEMBER 29, 2024
UK government commits to first men's health strategy Phil.
How the UK's austerity policies caused life expectancy to fall
Medical Xpress
NOVEMBER 29, 2024
Between 1945, when the second world war ended, and the start of the 2010s, average life expectancy and mortality rates in high-income countries improved continuously. But from around 2012, in the UK and in several other countries like the US, Germany and the Netherlands, the rate of improvement slowed, stopped, or even went into reverse.
Bayer opens Berlin incubator and welcomes first resident
pharmaphorum
NOVEMBER 29, 2024
Bayer's network of Co.
Long COVID appears to be driven by 'long infection.' Here's what the science says
Medical Xpress
NOVEMBER 29, 2024
Around 5%–10% of people with COVID infections go on to experience long COVID, with symptoms lasting three months or more.
Unlocking Excellence: How Catalent Is Transforming Japan’s Clinical Research
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
Part One: Overcoming challenges and seizing opportunities in global market access for rare and complex conditions
pharmaphorum
NOVEMBER 29, 2024
Part One: Overcoming challenges and seizing opportunities in global market access for rare and complex conditions Mike.
Why some people don't lose weight with Wegovy
Medical Xpress
NOVEMBER 29, 2024
Clinical trials have shown that people using weight-loss jabs, such as Wegovy and Mounjaro, lose anywhere between 16% and 21% of their body weight. But the drugs don't work for everyone.
Adragos Pharma Acquires Baccinex, Growing Sterile Manufacturing Services
Pharmaceutical Commerce
NOVEMBER 29, 2024
The transaction reaffirms the CDMO’s interest in growth on a global scale.
Study demonstrates how autonomic neurons control digestive functions
Medical Xpress
NOVEMBER 29, 2024
The autonomic nervous system orchestrates the functions of internal organs such as the heart and gut, serving as a connection between the brain and the rest of the body. It is classified in two divisions—the sympathetic and parasympathetic systems, often described as the body's accelerator and brake, respectively. For example, the sympathetic nervous system activates the "fight-or-flight" response in reaction to danger, concentrating energy on immediate survival and halting less urgent functions
How Machine Learning Drives Clinical Trial Efficiency
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
Let's personalize your content